Impact of filgotinib on sacroiliac joint MRI structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Walter P MaksymowychMikkel ØstergaardRobert LandewéWilliam BarchukKe LiuChantal TassetLeen GillesThijs HendrikxRobin BesuyenXenofon BaraliakosPublished in: Rheumatology (Oxford, England) (2021)
ClinicalTrials.gov, http://clinicaltrials.gov, NCT03117270.